Ab­b­Vie en­lists pro­tein degra­da­tion ex­perts at Mis­sion for a new bet on Alzheimer's, Parkin­son's

As a group of pre­clin­i­cal biotechs fo­cused on pro­tein degra­da­tion steadi­ly gath­ers steam, Ab­b­Vie is jump­ing on the band­wag­on al­beit steer­ing it to a some­what …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER